🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamid...
Status
Active Not Recruiting
Location
Regional Medical Center
Start Date
2003-11
Trial ID
NCT00070564
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, w...
Status
Completed
Location
Fairview Southdale Hospital
Start Date
2009-04
Trial ID
NCT00895414
Treatments Being Tested
The purpose of this study is to evaluate time to progression, overall survi...
Status
Completed
Location
Multiple Locations
Start Date
2004-12
Trial ID
NCT00103506
Treatments Being Tested
This study is being done to find out how effective a new treatment strategy...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-08
Trial ID
NCT00737438
Treatments Being Tested
This open-label Phase I study is designed to determine the maximum tolerate...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-06-02
Trial ID
NCT00875693
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Algemeen Ziekenhuis Middelheim
Start Date
1993-03
Trial ID
NCT00002517
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
The main purpose of this study is to see if pegfilgrastim (Neulasta) is saf...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2003-07
Trial ID
NCT00146562
Treatments Being Tested
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormon...
Status
Completed
Location
Cancer Research Campaign Trials Unit-Birmingham (CRCTU)
Start Date
1993-06
Trial ID
NCT00002582
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested